Journal
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 11, Issue 2, Pages 309-318Publisher
ASHLEY PUBLICATIONS LTD
DOI: 10.1517/13543784.11.2.309
Keywords
antifungal agents; antimicrobial peptide; defensin; histatin; lactoferrin; protegrin
Categories
Ask authors/readers for more resources
The increasing frequency of fungal infections in immunocompromised patients together with the emergence of strains resistant to currently used antifungal drugs point to an increased need for a new class of antimycotics. Antimicrobial peptides are promising candidates for the treatment of fungal infections since they have both mechanisms of action distinct from available antifungal agents and the ability to regulate the host immune defence systems as well. This review focuses on Candida albicans as a large amount of work on the mechanisms of action of classical antifungals as well as antimicrobial peptides, such as defensins, protegrins, histatins and lactoferrin (LF)-derived peptides, has been performed in this yeast. Analogues of these antimicrobial peptides and combinations of antimicrobial peptides with classical antimycotics are under investigation for treatment of candidiasis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available